Higher expression of vascular endothelial growth factor (VEGF) and increased AMFR worsen the disease conditions in patients with non-small cell lung cancer (Kara et al., 2001; Takanami et al., 2001). This evidence concerns the gene VEGFA and non-small cell lung carcinoma.